Collateral Therapeutics Pages on BioPortfolio:

BioPortfolio - Regeneration
Collateral Therapeutics Incorporated. Collateral's initial non-surgical gene therapy products under investigation are designed to promote and enhance ...
http://www.bioportfolio.com/indepth/Regeneration.html...

NASDAQ Biotechnology Companies - Barr - Dynacare
CIPH · CIPHERGEN BIOSYSTEMS INC, Nasdaq, Biotech. CBZ, COBALT CORP, NYSE, Services to Med Profs. CLTX · COLLATERAL THERAPEUTICS INC, Nasdaq, Biotech ...
http://www.bioportfolio.com/nasdaq/nasdaq_barr_dynacare.htm...

BioPortfolio - Perfusion
Reperfusion for acute ischemic stroke: arterial revascularization and collateral therapeutics. PURPOSE OF REVIEW: Reperfusion of the ischemic territory ...
http://www.bioportfolio.com/indepth/Perfusion.html...

BioPortfolio - Accentia BioPharmaceuticals - Profile
specialty pharmaceuticals and biologics for targeted therapeutics. ... undesirable collateral damage (i.e. toxicity), while boosting efficacy. ...
http://www.bioportfolio.com/biocorporate/30827-Accentia+BioP...

Progress in the treatment of peripheral arterial disease (PAD)
Novel therapeutics are being developed for the treatment of PAD: There are ... growth factors to induce the development of new collateral blood vessels. ...
http://www.bioportfolio.com/news/DailyUpdates_72.htm...

BioPortfolio News: Alexandria Real Estate Equities, Inc ...
Pfizer Inc. recently completed a sublease with Nektar Therapeutics, which will use this ... The collateral for this loan consists of six properties, ...
http://www.bioportfolio.com/news/Alexandria-Real-Estate-Equi...

BioPortfolio - Central Venous Pressure
Coronary Collateral Growth by External Counterpulsation: A Randomized ... Echo Therapeutics Announces Positive Results of a Clinical Study Testing ...
http://www.bioportfolio.com/indepth/Central_Venous_Pressure....

BioPortfolio - Argininosuccinate Synthase - InDepth
but collateral sensitivity to arginine auxotrophy in ovarian cancer. ... Therapeutics Daily: Nov 9 2009 11:02AM Matching: synthase ...
http://www.bioportfolio.com/indepth/Argininosuccinate_Syntha...

BioPortfolio - Head Lice
... collateral benefits and human safety in a hyperendemic tribal area of Orissa , ... Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing ...
http://www.bioportfolio.com/indepth/Head_Lice.html...

BioPortfolio - Peripheral Vascular Diseases - InDepth
... for the modulation of neovascularization and/or the growth of collateral arteries ... 7491550- Diagnostics and therapeutics for diseases associated with
...
http://www.bioportfolio.com/indepth/Peripheral_Vascular_Dise...

Results from other life science and pharmaceutical sites:

BioSpace - Collateral Therapeutics Inc. News, Search Jobs, Events
Collateral Therapeutics Inc. 11622 El Camino Real San Diego California 92130 U.S.A.. Phone: 858-794-3400 Fax: 858-794-3444 ...
http://www.biospace.com/company_profile.aspx?CompanyId=3386...

Collateral Therapeutics, Inc. Company Profile - Yahoo! Finance
No collateral damage here. Collateral Therapeutics, a subsidiary of Schering AG, develops gene therapies to treat various cardiovascular diseases as an ...
http://biz.yahoo.com/ic/56/56944.html...

Of Mice and Men: Essential Considerations in the Translation of ...
Variability of collateral flow across species, strains, and individuals, however , will ultimately determine the effect of collateral therapeutics. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27...

FGF-4 gene therapy GENERX--Collateral Therapeutics.
Collateral Therapeutics and Schering AG in Germany are developing a gene therapy product, GENERX for coronary artery disease. ...
http://www.ncbi.nlm.nih.gov/pubmed/11909005...

Halozyme Therapeutics - Board of Directors
His research and clinical work led to the founding of two successful biotechnology companies: Gensia, Inc., and Collateral Therapeutics, Inc. He also
...
http://www.halozyme.com/aboutus_board_of_directors.php...

Collateral therapeutics for cerebral ischemia.
Although specific collateral therapeutics are unrealized, insight may be gleaned from subtle details of prior stroke studies. Future advances will result ...
http://www.ncbi.nlm.nih.gov/pubmed/15853567...

PeriCor Therapeutics Elects Robert L. Engler, M.D. To Boa ...
He was also co-founder of Collateral Therapeutics (subsequently sold to Schering AG) and served as a Director from 1995 to 2000 and as Vice President, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=23544...

Of mice and men: essential considerations in the translation of ...
Of mice and men: essential considerations in the translation of collateral therapeutics. Liebeskind DS. Publication Types: Comment; Letter. Mesh Terms: ...
http://www.ncbi.nlm.nih.gov/pubmed/18845798...

RECOMBINANT DNA ADVISORY COMMITTEE (RAC) NATIONAL INSTITUTES OF ...
(University of California at San Diego, and a representative of Collateral Therapeutics, San Diego) provided oral responses during the RAC discussion. ...
http://oba.od.nih.gov/oba/RAC/summaries/06-98sum.pdf...

Reperfusion for acute ischemic stroke: arterial revascularization ...
Collateral therapeutics that enhance perfusion outside the ischemic core present novel dimension to acute stroke therapy, focused on ischemia and not just ...
http://www.ncbi.nlm.nih.gov/pubmed/19926989...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.